The Additional Costs per Month of Progression-Free Survival and Overall Survival: An Economic Model Comparing Everolimus with Cabozantinib, Nivolumab, and Axitinib for Second-Line...

por Swallow, Elyse, Messali, Andrew, Ghate, Sameer, McDonald, Evangeline, Duchesneau, Emilie, Perez, Jose Ricardo
Publicado 2018

Hepatitis A, B, and A/B vaccination series completion among US adults: A claims-based analysis

por Ghaswalla, Parinaz K., Patterson, Brandon J., Cheng, Wendy Y., Duchesneau, Emilie, Macheca, Monica, Duh, Mei Sheng
Publicado 2018

TRANSLATION OF A MEDICARE CLAIMS-BASED FRAILTY ALGORITHM FROM ICD-9-CM TO ICD-10-CM

por Faurot, Keturah, Duchesneau, Emilie, Shmuel, Shahar, Park, Jihye, Stürmer, Til, Jonsson-Funk, Michele L, Lund, Jennifer L
Publicado 2022

Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”

por Su, I-Hsuan, Lund, Jennifer L, Gaber, Charles E, Sanoff, Hanna K, Strassle, Paula D, Duchesneau, Emilie D
Publicado 2023

The Timing, the Treatment, the Question: Comparison of Epidemiologic Approaches to Minimize Immortal Time Bias in Real-World Data Using a Surgical Oncology Example

por Duchesneau, Emilie D., Jackson, Bradford E., Webster-Clark, Michael, Lund, Jennifer L., Reeder-Hayes, Katherine E., Nápoles, Anna M., Strassle, Paula D.
Publicado 2022

Missing data approaches in longitudinal studies of aging: A case example using the National Health and Aging Trends Study

por Duchesneau, Emilie D., Shmuel, Shahar, Faurot, Keturah R., Musty, Allison, Park, Jihye, Stürmer, Til, Kinlaw, Alan C., Yang, Yang Claire, Lund, Jennifer L.
Publicado 2023

Pathologic complete response and survival after neoadjuvant chemotherapy in cT1-T2/N0 HER2+ breast cancer

por An, Selena J., Duchesneau, Emilie D., Strassle, Paula D., Reeder-Hayes, Katherine, Gallagher, Kristalyn K., Ollila, David W., Downs-Canner, Stephanie M., Spanheimer, Philip M.
Publicado 2022